SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending as retail sentiment turned extremely bullish into the company's upcoming fiscal Q2 earnings report, after an analyst note argued BlackBerry's historically conservative guidance sets up revenue, EBITDA and EPS to come in above consensus; street models center on roughly $145.5 million in revenue, up about 12% year over year. The bull case leans heavily on QNX: traders are watching whether a newly discussed design win starts showing up in the roughly $950 million QNX royalty backlog  which management previously said contained no contribution from that win  and they cite NVIDIA's adoption of QNX 8.0 for automotive and physical AI operating systems, a SiftQNX telemetry partnership, and BlackBerry IVY partnerships as signs of the platform's expanding reach. The conversation is split, with bears repeatedly calling to short every pop and pointing to TSX short interest, while longs frame the setup as a potential squeeze with speculative price targets well above current levels.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin's sharp rebound into the mid-$86,000s is dominating the conversation, with traders describing a breakout to new levels and citing a weekly higher high with a bullish engulfing candle. The move has reignited a bull-versus-bear debate: bulls argue a new bull market is underway  some pointing to the relatively shallow prior drawdown as evidence of a more mature market  while bears call the rally a trap and flag liquidity and chart concerns. Short sellers are a running theme, with many traders mocking leveraged shorts caught on the wrong side of the move, though a few are still positioning for a pullback. Some participants note the recovery has coincided with broad risk appetite across equities  citing Meta, Nvidia and semiconductor gains  suggesting the move reflects renewed demand for risk assets rather than a crypto-specific catalyst. Discussion also extends to Strategy ($MSTR), with holders questioning why the stock is lagging bitcoin's advance and debating the company's bitcoin-buying approach.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Speculation that Novo Nordisk could pursue a significantly larger acquisition  after the company said its balance sheet could support deals well beyond small bolt-ons amid competitive pressure from Lilly in the obesity market  has put Viking Therapeutics at the center of heavy trader discussion, with chatter ranging from a partnership to a multi-billion-dollar buyout, though no deal has been confirmed. Layered on top is the community's central preoccupation: the anticipated Phase 3 readout for VK2735, Viking's GLP-1/GIP dual agonist viewed as a potential challenger to Lilly's tirzepatide. Bulls argue the drug is largely de-risked, that the stock's weakness rather than a run-up into the data sets up a better reaction than past sell-the-news setups, and that heavy short interest could fuel a squeeze. Bears counter with tolerability concerns, share dilution, and criticism of CEO Brian Lian's communication, with some predicting a slide toward single digits. The timing of the data itself remains speculative, with traders split on whether an announcement is imminent.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

HBAR is trending around the Clarity Act after a Senate vote to open debate on the crypto market-structure bill fell short, leaving SEC/CFTC jurisdiction  and potential commodity treatment for tokens like HBAR  unresolved. Traders tied a quick spike-and-fade in the token to the vote, split between bulls who see regulatory clarity as the token's key catalyst and skeptics who dismissed the move as a news-driven pump followed by selling, with some blaming market makers and several posts faulting Senate Democrats and a handful of Republicans for the failed vote. A smaller thread cited Grayscale's withdrawal of its HBAR ETF filing as a reason for weakness. Meanwhile, longer-term holders pointed to fundamentals  MainNet accounts approaching 10 million, SpaceDev joining the Hedera Council, and ISO 20022 relevance  against bears flagging failed resistance near $0.08 and a rising 200-day MA around $0.068 as the next technical test.

BlackBerry's QNX is dominating the conversation, with traders focused on its expansion into physical AI and robotics and its ties to NVIDIA. Posts celebrate NVIDIA signing up QNX 8.0 for automotive and physical AI operating systems, and debate whether certification across NVIDIA's robotics platforms would dramatically enlarge the addressable market. The prevailing bull framing is that robotics, medical, and other safety-critical verticals represent an expansion of QNX beyond automotive rather than a pivot, built on its real-time, deterministic, safety-certified edge over Linux. Mentions of a Momenta autonomous-driving collaboration, BMW partnership highlights, and speculation about additional OEM wins that could push the QNX backlog toward $1 billion add to the enthusiasm; one poster claims a short attack followed news of QNX SDP 8.0 expanding in China. A strong secondary thread is the September-quarter earnings report: the community is questioning the muted earnings-date announcement, cites a revenue consensus near $142.54 million, and is split between expectations of a clean quarter and skepticism over single-digit growth guidance. Bulls also circulate short-interest data showing a slight decline and claim shorting has become costly, while critics counter that the stock's weakness is justified and that only management, debenture holders, and shorts are profiting. Sharp retail infighting over individual trading claims runs throughout the board.

ProShares Trust - ProShares Bitcoin ETF

ProShares Bitcoin Strategy ETF

Bitcoins rebound and technical signs of a potential bottom are driving renewed interest in BITO, with bullish traders expecting the ETF to recover if BTC continues higher while bears warn of further downside. The community is also heavily debating BITOs sharply reduced distributions and ongoing NAV erosion, which have weakened its appeal as an income vehicle.

Maase, Inc. operates as a integrated provider and operator of artificial intelligence (AI) centric full-scene digital systems. The firm focus on areas of flexible energy deployment and intelligent commercial network operation, and provide closed-loop solutions from computing infrastructure, smart hardware and full-scene services, aiming to achieve large-scale implementation of AI technologies across industries. The company was founded by Hai Feng Yu on August 6, 2018 and is headquartered in Qingdao, China.

Maase Inc. - Ordinary Shares - Class A

Highest Performances Holdings Inc. - ADR

MAAS is drawing heavy attention as a small-cap AI infrastructure story backed by a fast cadence of business announcements: an RMB7.68M AI token-based services agreement, an RMB10M-plus Zhongchuang Liankong enterprise AI contract targeted for delivery within seven to eight weeks, and an RMB1.65M deal in which five compute nodes were delivered, client acceptance was completed, and payment was collected in full. Traders also point to the Lingyan Miaoyu LLM generating B2B revenue, a consumer access portal launch, 800VDC power-delivery moves by subsidiary Huazhi Future, and even a national entrepreneurship competition prize as evidence the company is building across compute, models, and energy. The news flow has collided with momentum: heavy volume, price coiling above the 20/60/120-day moving averages after an approximately 100% rally, and talk of a consolidation-triangle breakout, with one trader floating a $32 short-term target. Reaction is split. Bulls argue the steady contract flow and clean execution evidence show real AI revenue rather than an AI label, while skeptics counter that individual contracts are modest, that research teams and PR do not equal revenue, and that they want price-and-volume confirmation before chasing the move.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD's surge into the $1 trillion market cap club is the dominant topic, with traders noting the stock has joined Nvidia, Broadcom and Micron among trillion-dollar U.S. companies after a run they estimate has added roughly $300 billion in market value as part of a broader AI-chip rally lifting peers like Intel, Arm and Micron. Reaction is sharply divided: many are celebrating the milestone and warning that shorting the momentum is a mistake, describing squeeze-like conditions and FOMO around the round-number milestone, while skeptics call the move a casino-like market detached from fundamentals  citing the share price against modest EPS, some traders expecting valuation-driven downgrades, and complaints that the rally has come on limited fresh news beyond AI-chip optimism and the OpenAI partnership, including its low-strike warrants. A recurring debate is whether the stock near $600 is a short opportunity or a trap, and some traders attribute the relentless rise to hedge fund and market-maker manipulation.

On Holding AG engages in the development and distribution of sports products such as footwear, apparel, and accessories for high-performance running, outdoor, all-day activities, and tennis. It sells its products worldwide through independent retailers and global distributors, its own online presence, and its own stores. The company was founded by David Allemann, Olivier Bernhard, and Caspar Coppetti in January 2010 and is headquartered in Zurich, Switzerland.

On Holding AG - Ordinary Shares Class A

On Holding AG

On Holding's steep post-earnings slide is dominating the conversation. Traders are reacting to a Q2 report showing revenue of CHF 850.3M versus roughly CHF 879.6M consensus, with EPS of CHF 0.35 narrowly beating the CHF 0.34 estimate, alongside a cut to the growth outlook that traders say management framed as protecting price integrity. The response was a record single-day drop for the name and a slide to 52-week lows, and the community is split: many call the selloff an overreaction for what they view as the sector's fastest-growing, best-margin company, while others argue the guidance cut confirmed weaker demand, fault management credibility, and note short sellers and put buyers have been consistently on the winning side. Debate continues over whether the decline is company-specific or part of broader sportswear weakness and industry-wide discounting hitting Nike, Lululemon, and Deckers. Two follow-on catalysts drew attention but little market enthusiasm: Kylian Mbapp's signing from Nike  debated as a game-changing entry into football versus an expensive bet  and an investor-day update setting 2029 financial targets plus a $1 billion buyback, which some traders see as deliberately conservative and spread over more than three years, limiting its near-term EPS impact.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk shares are trending on a sharp sell-off, with traders debating whether the company's Capital Markets Day (CMD 2026)  where management guided to mid-single-digit revenue growth and emphasized diversifying beyond semaglutide  explains the decline, or whether the drop is disconnected from the updates. Bears in the discussion fault management for losing GLP-1 market share while over-relying on one franchise, dismissed the rebrand to 'Novo' as tone-deaf amid the slide, and pointed to bearish analyst downgrades and mounting pricing/competition pressure, with some arguing the market simply 'hates' the company and its CEO. Bulls counter that the sell-off has 'no basis,' citing a single-digit P/E at a historical low, an oral Wegovy launch that appears to be expanding the obesity market rather than cannibalizing injectables, and the view that obesity treatment is less winner-take-all than assumed. NVO's underperformance versus Eli Lilly  down more than 17% versus Lilly's 6.7% gain  frames the bear case, though dip-buying keeps sentiment sharply divided.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
